Efficacy of tilt training in patients with vasovagal syncope

Kardiologia Polska

Volumn 64, Issue 6, 2006, Pages 602-608

  Gajek, Jacek ^a,b   Zyśko, Dorota ^a   Mazurek, Walentyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

Author keywords

Tilt training; Vasovagal syncope

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; RECURRENT DISEASE; SYNCOPE; TILT TABLE TEST;

EID: 33747362874     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Porges SW. The polyvagal theory: phylogenetic substrates of a social nervous system. Int J Psychophysiol 2001; 42: 123-46.
2. Fitzpatrick AP, Theodorakis G, Vardas P, et al. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17: 125-30.
3. Brignole M, Alboni P, Benditt DG, et al. Guidelines on management (diagnosis and treatment) of syncope - update 2004. Europace 2004; 6: 467-537.
4. Ector H, Reybrouck T, Heidbuchel H, et al. Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance. Pacing Clin Electrophysiol 1998; 21: 193-6.
5. Di Girolamo E, Di Iorio C, Leonzio L, et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study. Circulation 1999; 100: 1798-801.
6. Abe H, Kondo S, Kohshi K, et al. Usefulness of orthostatic self-training for the prevention of neurocardiogenic syncope. Pacing Clin Electrophysiol 2002; 25: 1454-8.
7. Kinay O, Yazici M, Nazli C, et al. Tilt training for recurrent neurocardiogenic syncope: effectiveness, patient compliance, and scheduling the frequency of training sessions. Jpn Heart J 2004; 45: 833-43.
8. Reybrouck T, Heidbuchel H, Van de Werf F, et al. Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2000; 23: 493-8.
9. Numata T, Abe H, Nagatomo T, et al. Successful treatment of malignant neurocardiogenic syncope with repeated tilt training program. Jpn Circ J 2000; 64: 406-9.
10. Foglia-Manzillo G, Giada F, Gaggioli G, et al. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace 2004; 6: 199-204.
11. Hawkey A. The physical price of a ticket into space. J Br Interplanet Soc 2003; 56: 152-9.
12. Convertino VA. Value of orthostatic stress in maintaining functional status soon after myocardial infarction or cardiac artery bypass grafting. J Cardiovasc Nurs 2003; 18: 124-30.
13. Zhang LN, Gao F, Ma J, et al. Daily head-up tilt, standing or centrifugation can prevent vasoreactivity changes in arteries of simulated weightless rats. J Gravit Physiol 2000; 7: P143-4.
14. Gajek J., Zyśko D.: Tilt training program influences the renin-angiotensin-aldosterone system (RAAS) activity in patients with vasovagal syncope. Eur Heart J 2003; 24 (Abstr. Suppl.): 266.
15. Kosinski DJ, Grubb BP. Neurally mediated syncope with an update on indications and usefulness of head-upright tilt table testing and pharmacologic therapy. Curr Opin Cardiol 1994; 9: 53-64.
16. Malik P, Koshman ML, Sheldon R. Timing of first recurrence of syncope predicts syncopal frequency after a positive tilt table test result. J Am Coll Cardiol 1997; 29: 1284-9.
17. Sheldon R, Rose S. Components of clinical trials for vasovagal syncope. Europace 2001; 3: 233-40.
18. Madrid AH, Ortega J, Rebollo JG, et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001; 37 :554-9.
19. Leor J, Rotstein Z, Vered Z, et al. Absence of tachycardia during tilt test predicts failure of beta-blocker therapy in patients with neurocardiogenic syncope. Am Heart J 1994; 127: 1539-43.
20. Raviele A, Giada F, Menozzi C, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 2004; 25: 1741-8.
21. Connolly SJ, Sheldon R, Roberts RS, et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 16-20.
22. Lafuente EA, Martinez LC, Moguel JO, et al. Response to treatment during medium-term follow-up in a series of patients with neurocardiogenic syncope. Arch Med Res 2004; 35: 416-20.
23. Gatzoulis K, Sideris S, Theopistou A, et al. Long-term outcome of patients with recurrent syncope of unknown cause in the absence of organic heart disease and relation to results of baseline tilt table testing. Am J Cardiol 2003; 92: 876-9.